Back to news
Why Switzerland deserves a quality premium
The world's most innovative economy, for the 15th consecutive year
Switzerland claimed the #1 position in the WIPO Global Innovation Index 2025 with a score of 66.0, extending an unbroken streak dating back to 2011. Sweden (62.6) and the United States (61.7) trailed by meaningful margins. Germany, notably, dropped from 9th to 11th, pushed out of the top ten by China's first-ever entry at 10th. Switzerland scored particularly strongly in creative outputs (1st globally), knowledge and technology outputs (2nd), and market sophistication (3rd), confirming its unique blend of inventive capacity and commercial translation.
The innovation machine runs on extraordinary R&D investment. Switzerland allocates approximately 3.2–3.4% of GDP to research and development, the OECD's most recent official figure (2023) is 3.22%, while the Swiss government's running estimate reaches ~3.4% depending on measurement scope. This places Switzerland well above the EU average of ~2.2% and the OECD average of 2.7%, trailing only Israel (6.33%), South Korea (5.32%), and Japan (3.45%) globally. The private sector funds over two-thirds of this total, reflecting genuine corporate commitment rather than government subsidy.
Patent output per capita is where Switzerland truly separates from peers. The EPO Patent Index 2024 recorded 9’966 Swiss applications, a 3.2% increase marking the fourth consecutive year of growth and roughly 40% more than 2015. The per-capita figure of 1’140 patent applications per million inhabitants is the highest in the world by a wide margin; Sweden follows at 472, Germany at approximately 300. Medical technology (10.5% of filings), measurement technology (9.1%), and electrical machinery (8.2%, growing at 8.9%) lead Swiss patent sectors.
Swiss small and mid-caps are outperforming again after a valuation reset
The SPI Extra index, tracking Swiss small and mid-cap companies outside the 20 largest SMI names, has delivered a long-term annualized return of 10.0% per annum over 2003–2024, substantially ahead of the broader SPI (7.7%) and the blue-chip SMI (5.7%). Since 2002, cumulative total returns tell the story even more starkly: 479% for SPI Extra versus 225% for the SMI.
After a difficult 2022–2024 period driven by rising interest rates, Swiss small and mid-caps staged a notable recovery. From Q2 2025 onward, the SPI Extra outperformed both the broader SPI and the SMIM Index, supported by the SNB's aggressive rate-cutting cycle. VP Bank's June 2025 analysis found Swiss small and mid-caps trading at a 13% discount to their 10-year average price-to-earnings ratio, a valuation trough comparable to the 2008 financial crisis and representing a potential entry point. The SPI itself rose approximately 9% year-over-year by early 2026.
A structural advantage of the SPI Extra over the SMI is sector diversification. The SMI concentrates roughly 80% in three sectors (healthcare, consumer staples, finance). The SPI Extra distributes approximately 67% across industrials, finance, and healthcare, providing far greater exposure to Switzerland's innovative industrial Mittelstand, the precision-engineering, automation, and semiconductor supply-chain companies that drive the quality premium thesis.
Corporate governance reinforces the premium
Switzerland's corporate governance framework was significantly upgraded by a comprehensive company law reform effective January 1, 2023, introducing mandatory say-on-pay for listed companies (codifying the 2013 Minder Initiative into statute), lowered thresholds for shareholder agenda items, and legal frameworks for virtual shareholder meetings. The revised Swiss Code of Best Practice, published by economiesuisse in 2023, tightened standards further. Switzerland ranked 3rd in Europe for activist campaigns (behind the UK and Germany) in 2024–2025, accounting for approximately 13% of all European activism, a sign of both governance quality and investor engagement.
The University of St. Gallen's Elite Quality Index 2025 ranked Switzerland 3rd globally (behind Singapore and the US), citing its "transparency, decentralization, and accountability." The Swisscanto ESG Sovereign Rating 2025 placed it 4th globally for governance quality (behind Denmark, Norway, and Iceland). Swisscanto Lombard Odier's characterization captures the synthesis: Swiss companies "stand out in terms of key financial metrics such as earnings growth, profit margins, return on invested capital, and free cash flow generation", a quality premium justified by superior fundamentals, not mere sentiment.
Author
Dylan Figueiredo
CIO | Haute Capital Partners SA
Media & General inquiries
Haute Capital Partners SA | +41 32 321 35 35 | info@haute.com
DISCLAIMER
This publication constitutes neither an offer to sell nor a solicitation to buy securities of the Company and it does not constitute a prospectus or a similar communication within the meaning of article 652a, 752 and/or 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the BX Swiss. The listing is being made solely by means of and based on the published securities prospectus (including any amendments thereto, if any). An investment decision regarding the securities of the Company should only be made based on the securities prospectus. The prospectus is available free of charge in Switzerland for 12 months following the first day of trading at HAUTE CAPITAL PARTNERS SA, Plänkestrasse 32, 2502 Biel/Bienne, Switzerland. This communication is being distributed only to, and is directed only at (i) persons outside the United Kingdom, (ii) persons who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth entities, and other persons to whom it may otherwise lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Any person who is not a Relevant Person must not act or rely on this communication or any of its contents. This communication does not constitute an "offer of securities to the public" within the meaning of Regulation (EU) 2017/1129 (the "Prospectus Regulation") of the securities referred to in it (the "Securities") in any member state of the European Economic Area (the "EEA"). The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to US persons (as such term is defined in Regulation S under the Securities Act) unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. The issuer of the securities has not registered, and does not intend to register, any portion of the securities in the United States, and does not intend to conduct a public offering of securities in the United States.